Are allergic fungal rhinosinusitis and allergic bronchopulmonary aspergillosis lifelong conditions? (Q38948097)

7 September 2017

1 reference

title

Are allergic fungal rhinosinusitis and allergic bronchopulmonary aspergillosis lifelong conditions? (English)

1 reference

allergic bronchopulmonary aspergillosis

7 September 2017

0 references

0 references

1 reference

Arunaloke Chakrabarti

series ordinal

3

object named as

Arunaloke Chakrabarti

1 reference

7 September 2017

Ritesh Agarwal

1

1 reference

7 September 2017

Sandeep Bansal

series ordinal

2

1 reference

7 September 2017

language of work or name

1 reference

6 September 2016

1 reference

7 September 2017

1 reference

7 September 2017

volume

55

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

87-95

1 reference

The clinical spectrum of pulmonary aspergillosis

7 September 2017

cites work

1 reference

Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview

21 January 2018

1 reference

Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies

21 January 2018

1 reference

Sinobronchial allergic mycosis: the SAM syndrome

21 January 2018

1 reference

Surface hydrophobin prevents immune recognition of airborne fungal spores

21 January 2018

1 reference

The RodA hydrophobin on Aspergillus fumigatus spores masks dectin-1- and dectin-2-dependent responses and enhances fungal survival in vivo.

21 January 2018

1 reference

Innate immunity to Aspergillus species

21 January 2018

1 reference

Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients.

21 January 2018

1 reference

Cytokines induce effector T-helper cells during invasive aspergillosis; what we have learned about T-helper cells?

21 January 2018

1 reference

Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity.

21 January 2018

1 reference

Immunopathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis

21 January 2018

1 reference

Proteases from Aspergillus fumigatus induce interleukin (IL)-6 and IL-8 production in airway epithelial cell lines by transcriptional mechanisms

21 January 2018

1 reference

Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production

21 January 2018

1 reference

21 January 2018

ILC2s and fungal allergy

1 reference

Suppression of epithelial signal transducer and activator of transcription 1 activation by extracts of Aspergillus fumigatus

21 January 2018

1 reference

Role of Aspergillus fumigatus in Triggering Protease-Activated Receptor-2 in Airway Epithelial Cells and Skewing the Cells toward a T-helper 2 Bias.

21 January 2018

1 reference

Concomitant allergic bronchopulmonary aspergillosis and allergic Aspergillus sinusitis: a review of an uncommon association*.

21 January 2018

1 reference

Allergic fungal airway disease: pathophysiologic and diagnostic considerations

21 January 2018

1 reference

Culture-positive allergic fungal sinusitis

21 January 2018

1 reference

Epidemiology of chronic fungal rhinosinusitis in rural India.

21 January 2018

1 reference

Fungal-specific humoral response in eosinophilic mucus chronic rhinosinusitis.

21 January 2018

1 reference

Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference

21 January 2018

1 reference

Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria

21 January 2018

1 reference

Cut-off values of serum IgE (total and A. fumigatus -specific) and eosinophil count in differentiating allergic bronchopulmonary aspergillosis from asthma

21 January 2018

1 reference

Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis

21 January 2018

1 reference

Allergic fungal rhinitis and rhinosinusitis

21 January 2018

1 reference

Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India.

21 January 2018

1 reference

Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients.

21 January 2018

1 reference

Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.

21 January 2018

1 reference

Allergic bronchopulmonary aspergillosis: staging as an aid to management

21 January 2018

1 reference

An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus

21 January 2018

1 reference

Allergic bronchopulmonary aspergillosis with aspergilloma: an immunologically severe disease with poor outcome

21 January 2018

1 reference

The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial.

21 January 2018

1 reference

Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization

21 January 2018

1 reference

Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis.

21 January 2018

1 reference

Omalizumab, an anti-immunoglobulin E antibody: state of the art.

21 January 2018

1 reference

Role of inhaled amphotericin in allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).

21 January 2018

1 reference

A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

Fungal rhinosinusitis: what every allergist should know

21 January 2018

1 reference

Treatment of allergic fungal sinusitis: a comparison trial of postoperative immunotherapy with specific fungal antigens.

21 January 2018

1 reference

Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole

21 January 2018

1 reference

The role of itraconazole in recalcitrant fungal sinusitis

21 January 2018

1 reference

Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis

21 January 2018

1 reference

Allergic Bronchopulmonary Aspergillosis

21 January 2018

1 reference

Aspergillushypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA?

21 January 2018

1 reference

Performance of serum galactomannan in patients with allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

What is the current place of azoles in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization

21 January 2018

1 reference

Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations

21 January 2018

1 reference

Immunity to fungal infections

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1093/MMY/MYW071

1 reference

7 September 2017

1 reference